Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PeRinatal Outcomes With ACTive Versus Expectant Management of Women With Pre-labor Rupture Of Membranes: a Phase III, Open-label, Randomized Controlled Multicentric Trial

NCT05958953 is registered in ClinicalTrials.gov with University of Modena and Reggio Emilia as lead sponsor.

NCT NCT05958953
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05958953 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PeRinatal Outcomes With ACTive Versus Expectant Management of Women With Pre-labor Rupture Of Membranes: a Phase III, Open-label, Randomized Controlled Multicentric Trial
Lead sponsor
University of Modena and Reggio Emilia
Phase
Phase 3
Overall status
Unknown status
Start date
September 30, 2023
Completion date
November 12, 2025
Enrollment
1,400 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

delayed delivery after spontaneous or unspecified rupture of membranes, distress; fetal, complicating delivery, maternal sepsis, rupture of membranes; premature